A peer-reviewed study funded by BD published in the journal Clinical Infectious Diseases suggests that its Veritor antigen test outperformed a PCR test in detecting people contagious and with symptoms of COVID-19.
The data adds to a debate about faster and cheaper antigen tests and how they should be used when compared to lab-based PCR tests, more sensitive and long considered the gold standard of detecting the virus.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,